This Slide: #17 of 100 |
Slide #17. Quest Diagnostics — Solstas Lab Partners
Acquirer:
Quest Diagnostics (NYSE:DGX)
Acquiree:
Solstas Lab Partners
Details:
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has completed the previously announced acquisition of Solstas Lab Partners Group and its subsidiaries (Solstas), a full-service commercial laboratory company based in Greensboro, North Carolina. The combination of Solstas with Quest Diagnostics will give patients and healthcare providers in the Southeastern United States, where Solstas operates in nine states, including the Carolinas, Virginia, Tennessee, Georgia and Alabama, greater access to innovative and cost-effective diagnostic information services.
Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
Quest Diagnostics SEC Filing Email Alerts Service
Open the DGX Page at The Online Investor »
|
Open the DGX Page at The Online Investor (in a new window) »
Free DGX Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.53 out of 4) 6th percentile
(ranked lower than approx. 94% of all stocks covered)
Analysts' Target Price: DGX Stock Forecast Based on Zacks ABR data; powered by Xignite |